Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Arnold

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancerJean-Yves Douillard, Christian Peschel, Frances Shepherd, et al.
The New England Journal of Medicine|October 31, 2003
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinomaTrisha M Shattuck, Stiina Välimäki, Takao Obara, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 17, 2022
Epidemiology, Pathophysiology, and Genetics of Primary HyperparathyroidismSalvatore Minisola, Andrew Arnold, Zhanna Belaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing dataLouise Bordeleau, John Paul Szalai, Marguerite Ennis, et al.
The Journal of Clinical Investigation|February 7, 2012
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in miceMathew C Casimiro, Marco Crosariol, Emanuele Loro, et al.
Clinical Endocrinology|July 17, 2003
Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinomaTrisha M Shattuck, Teresa S Kim, Jessica Costa, et al.
Cancer Research|November 25, 2003
Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidismSteven K Libutti, Judy S Crabtree, Dominique Lorang, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18Natasha B Leighl, Luis Paz-Ares, Jean-Yves Douillard, et al.
JCI Insight|August 17, 2021
Mutations in EPHB4 cause human venous valve aplasiaOliver Lyons, James Walker, Christopher Seet, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancerJean-Yves Douillard, Christian Peschel, Frances Shepherd, et al.
The New England Journal of Medicine|October 31, 2003
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinomaTrisha M Shattuck, Stiina Välimäki, Takao Obara, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 17, 2022
Epidemiology, Pathophysiology, and Genetics of Primary HyperparathyroidismSalvatore Minisola, Andrew Arnold, Zhanna Belaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing dataLouise Bordeleau, John Paul Szalai, Marguerite Ennis, et al.
The Journal of Clinical Investigation|February 7, 2012
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in miceMathew C Casimiro, Marco Crosariol, Emanuele Loro, et al.
Clinical Endocrinology|July 17, 2003
Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinomaTrisha M Shattuck, Teresa S Kim, Jessica Costa, et al.
Cancer Research|November 25, 2003
Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidismSteven K Libutti, Judy S Crabtree, Dominique Lorang, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18Natasha B Leighl, Luis Paz-Ares, Jean-Yves Douillard, et al.
JCI Insight|August 17, 2021
Mutations in EPHB4 cause human venous valve aplasiaOliver Lyons, James Walker, Christopher Seet, et al.
Pageof 9